Mohr M - Search Results

1

Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.

Mohr M, Dalmis F, Hilgenfeld E, Oelmann E, Zühlsdorf M, Kratz-Albers K, Nolte A, Schmitmann C, Onaldi-Mohr D, Cassens U, Serve H, Sibrowski W, Kienast J, Berdel WE. Mohr M, et al. Clin Cancer Res. 2001 Jan;7(1):51-7. Clin Cancer Res. 2001. PMID: 11205918

2

Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.

Hoppe B, Mohr M, Roots-Weiss A, Kienast J, Berdel WE. Hoppe B, et al. Among authors: mohr m. Bone Marrow Transplant. 1999 Apr;23(8):809-17. doi: 10.1038/sj.bmt.1701656. Bone Marrow Transplant. 1999. PMID: 10231144

3

Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.

Mohr M, Hilgenfeld E, Fietz T, Hoppe B, Koenigsmann M, Hoffmann M, Knauf WU, Cassens U, Sibrowski W, Kienast J, Thiel E, Berdel WE. Mohr M, et al. Clin Cancer Res. 1999 May;5(5):1035-40. Clin Cancer Res. 1999. PMID: 10353736 Clinical Trial.

4

Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).

Cassens U, Momkvist PH, Zuehlsdorf M, Mohr M, Kienast J, Berdel WE, Sibrowski W. Cassens U, et al. Among authors: mohr m. Bone Marrow Transplant. 2001 Jul;28(1):13-20. doi: 10.1038/sj.bmt.1703082. Bone Marrow Transplant. 2001. PMID: 11498739 Clinical Trial.

5

Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.

Oelmann E, Thomas M, Serve H, Kienast J, Zühlsdorf M, Mohr M, Klinke F, Dölken G, Macha H, Schmidt EW, Berdel WE. Oelmann E, et al. Among authors: mohr m. Oncology. 2002;63(3):248-53. doi: 10.1159/000065473. Oncology. 2002. PMID: 12381904 Clinical Trial.

6

Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.

Kessler T, Mohr M, Müller-Tidow C, Krug U, Brunnberg U, Mohr B, Schliemann C, Sauerland C, Serve H, Büchner T, Berdel WE, Mesters RM. Kessler T, et al. Among authors: mohr b, mohr m. Leuk Res. 2008 Mar;32(3):491-4. doi: 10.1016/j.leukres.2007.06.015. Epub 2007 Aug 1. Leuk Res. 2008. PMID: 17675230 Clinical Trial.

7

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients.

Brunnberg U, Mohr M, Noppeney R, Dürk HA, Sauerland MC, Müller-Tidow C, Krug U, Koschmieder S, Kessler T, Mesters RM, Schulz C, Kosch M, Büchner T, Ehninger G, Dührsen U, Serve H, Berdel WE. Brunnberg U, et al. Among authors: mohr m. Ann Oncol. 2012 Apr;23(4):990-6. doi: 10.1093/annonc/mdr346. Epub 2011 Aug 2. Ann Oncol. 2012. PMID: 21810729 Free article. Clinical Trial.

8

High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.

Mohr M, Hartig I, Kessler T, Hamisch C, Kliesch S, Krug U, Spieker T, Semik M, Wiebe K, Pühse G, Hertle L, Liersch R, Müller-Tidow C, Mesters RM, Berdel WE. Mohr M, et al. Bone Marrow Transplant. 2012 Oct;47(10):1321-5. doi: 10.1038/bmt.2012.14. Epub 2012 Feb 13. Bone Marrow Transplant. 2012. PMID: 22327130 Clinical Trial.

9

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

Mikesch JH, Kuhlmann M, Demant A, Krug U, Thoennissen GB, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel WE, Thoennissen NH. Mikesch JH, et al. Among authors: mohr m. Ann Hematol. 2013 Aug;92(8):1041-8. doi: 10.1007/s00277-013-1738-9. Epub 2013 Mar 27. Ann Hematol. 2013. PMID: 23532626

10

Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.

Schmidt LH, Görlich D, Spieker T, Rohde C, Schuler M, Mohr M, Humberg J, Sauer T, Thoenissen NH, Huge A, Voss R, Marra A, Faldum A, Müller-Tidow C, Berdel WE, Wiewrodt R. Schmidt LH, et al. Among authors: mohr m. J Thorac Oncol. 2014 Sep;9(9):1294-304. doi: 10.1097/JTO.0000000000000243. J Thorac Oncol. 2014. PMID: 25036876 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters